Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)

NCT00993525 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: Intravitreal injection of ranibizumab

Sponsor

University of Sao Paulo

Collaborators

[object Object]
[object Object]